Clinical Trial

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

Study acronym: MIRACLE
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doctors better identify different types of cardiogenic shock and better predict outcomes in adults hospitalized with acute heart failure and cardiogenic shock. The main question is whether clinical findings, imaging results, and biomarkers, including sex-specific factors, are associated with the risk of death within 30 days. Participants will not receive an experimental treatment. Researchers will collect data from routine care, collect additional blood and urine samples for biobanking, and follow participants after hospital discharge
Trial Details
NCT Number NCT07515508
Lead Sponsor University Heart Center Freiburg - Bad Krozingen
Conditions Cardiogenic Shock, Acute Heart Failure (AHF)
Enrollment 600 participants
Start Date 2024-08-07
Primary Completion 2027-07-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29